Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.19.3 extracted from

  • Schaeffer, M.; de Miranda, A.; Mottram, J.C.; Coombs, G.H.
    Differentiation of Leishmania major is impaired by over-expression of pyroglutamyl peptidase I (2006), Mol. Biochem. Parasitol., 150, 318-329.
    View publication on PubMed

Activating Compound

Activating Compound Comment Organism Structure
dithiothreitol at least 10 mM required for full activity Leishmania major
tris(2-carboxyethyl)phosphine at least 0.5 mM required for full activity Leishmania major

Application

Application Comment Organism
medicine overexpression of active PPI in Leishmania major impairs differentiation from the procyclic promastigote to the infective metacyclic promastigote. PPI does not protect against the natural antimicrobial peptide gomesin Leishmania major

Cloned(Commentary)

Cloned (Comment) Organism
N-terminal His-tagged native or mutant PPI expressed in Escherichia coli BL21(DE3) Leishmania major

Protein Variants

Protein Variants Comment Organism
C210A no detectable activity Leishmania major
E101Q ca. 2% activity of the native enzyme Leishmania major
E107Q ca. 50% activity of the native enzyme Leishmania major
H234S no detectable activity Leishmania major
additional information PPI-deficient mutants show no detectable phenotype, retain infectivity to macrophages in vitro and in mice Leishmania major

Inhibitors

Inhibitors Comment Organism Structure
2-Pyrrolidinone 1 mM inhibits by 44% Leishmania major
Cu2+ 1 mM inhibits by 91.3% Leishmania major
iodoacetamide 0.1 mM strongly inhibits by 98.3% Leishmania major
iodoacetic acid 0.1 mM completely inhibits Leishmania major
additional information Ca2+, Mg2+, Na+, Li+, pepstatin A, 1,10-phenanthroline, benzamidine, bestatin and trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane have no or little inhibitory effect Leishmania major
N-ethylmaleimide 0.1 mM strongly inhibits by 98.1% Leishmania major
Ni2+ 1 mM inhibits by 99%, 0.1 mM inhibits by 48% Leishmania major
phenylmethylsulfonyl fluoride 1 mM inhibits by 53.4% Leishmania major
Zn2+ 1 mM inhibits by 80.2% Leishmania major

KM Value [mM]

KM Value [mM] KM Value Maximum [mM] Substrate Comment Organism Structure
0.0335
-
L-pyroglutamyl p-nitroanilide
-
Leishmania major

Localization

Localization Comment Organism GeneOntology No. Textmining
cytosol
-
Leishmania major 5829
-

Molecular Weight [Da]

Molecular Weight [Da] Molecular Weight Maximum [Da] Comment Organism
30270
-
sequence analysis Leishmania major
36000
-
gel filtration Leishmania major

Organism

Organism UniProt Comment Textmining
Leishmania major
-
-
-

Purification (Commentary)

Purification (Comment) Organism
by Ni-affinity chromatography and gel filtration Leishmania major

Source Tissue

Source Tissue Comment Organism Textmining
promastigote
-
Leishmania major
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
L-pyroglutamyl-beta-naphthylamide + H2O
-
Leishmania major L-pyroglutamate + 2-naphtylamine
-
?
L-pyroglutamyl-p-nitroanilide + H2O
-
Leishmania major L-pyroglutamate + p-nitroaniline
-
?

Synonyms

Synonyms Comment Organism
PPI
-
Leishmania major
pyroglutamyl aminopeptidase I
-
Leishmania major

pH Optimum

pH Optimum Minimum pH Optimum Maximum Comment Organism
additional information
-
optimal activity between 8.8-10.5, activity decreases rapidly below pH 8.0 Leishmania major